Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of At-home Solifenacin Titration in OAB
NCT00759577Phase 4Terminated
- Sponsor
- NYU Langone Health
- Start
- Sep 2008
- Primary completion
- May 2010
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of solifenacin in overactive bladder (OAB), sponsored by NYU Langone Health. Started Sep 2008; status: terminated.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00759577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00759577.